FIELD: medicine. SUBSTANCE: method involves administering 5-fluoro-uracyl from the first to the fifth day in pre- and postoperative period at a daily dose of 1000 mg/m2 by applying continuous 120-h infusion method. Cyclophosphan is administered at a daily dose of 600 mg/m2 and metatrexate at a daily dose of 40 mg/m2 in single intravenous injection. EFFECT: enhanced effectiveness of treatment.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS POSSESSING DIFFUSE FORMS OF MAMMARY GLAND CARCINOMA | 1996 |
|
RU2133607C1 |
| METHOD OF TREATING PATIENTS WITH OPERABLE MAMMARY GLAND CANCER | 2004 |
|
RU2288710C2 |
| METHOD OF TREATMENT OF PATIENTS WITH DISSEMINATED FORMS OF BREAST CANCER | 1996 |
|
RU2131734C1 |
| METHOD OF OPERABLE BREAST CANCER MEDICAL TREATMENT | 2006 |
|
RU2325914C2 |
| METHOD FOR TREATING PATIENTS HAVING NONOPERABLE FORMS OF FLAT CELL CANCER LOCALIZED ON MUCOUS MEMBRANE OF ORAL CAVITY ORGANS AND ORGANS OF ORAL REGION OF THROAT | 1995 |
|
RU2096999C1 |
| METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
| METHOD OF BREAST CANCER TREATMENT | 2007 |
|
RU2372858C2 |
| METHOD FOR TREATING THE CASES OF MAMMALIAN GLAND CARCINOMA | 2001 |
|
RU2203687C2 |
| METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED STOMACH CANCER | 2011 |
|
RU2461375C1 |
| METHOD OF TREATMENT OF LOCALLY ADVANCED BREAST CANCER | 2007 |
|
RU2348419C2 |
